A Novel Non-Invasive Device for the Assessment of Central Venous Pressure in Hospital, Office and Home

Marcelli, Emanuela; Cercenelli, Laura; Bortolani, Barbara; Marini, Saverio; Arfilli, Luca; Capucci, Alessandro; Plicchi, Gianni

doi:10.2147/mder.s307775

Cited by 2 publications

(1 citation statement)

References 78 publications

(127 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This device operates on the principle of venous occlusive plethysmography, extensively used for other applications in a clinical setting. Limitations of this technique requires the patients to be mobilized with the cuffs connected to a graphical user interface system [ 28 ]. Moreover, it requires clinical validation in a certain group of HF patients with multiple comorbidities to determine the accuracy of measurements, as any pathophysiologic changes affecting the pressures between left ventricle and right atrium can affect the measured CVP.…”

Section: Introductionmentioning

confidence: 99%

Design and Haemodynamic Analysis of a Novel Anchoring System for Central Venous Pressure Measurement

Manavi

Ijaz

O’Grady

et al. 2022

Sensors

View full text Add to dashboard Cite

Background/Objective: In recent years, treatment of heart failure patients has proved to benefit from implantation of pressure sensors in the pulmonary artery (PA). While longitudinal measurement of PA pressure profoundly improves a clinician’s ability to manage HF, the full potential of central venous pressure as a clinical tool has yet to be unlocked. Central venous pressure serves as a surrogate for the right atrial pressure, and thus could potentially predict a wider range of heart failure conditions. However, it is unclear if current sensor anchoring methods, designed for the PA, are suitable to hold pressure sensors safely in the inferior vena cava. The purpose of this study was to design an anchoring system for accurate apposition in inferior vena cava and evaluate whether it is a potential site for central venous pressure measurement. Materials and Methods: A location inferior to the renal veins was selected as an optimal site based on a CT scan analysis. Three anchor designs, a 10-strut anchor, and 5-struts with and without loops, were tested on a custom-made silicone bench model of Vena Cava targeting the infra-renal vena cava. The model was connected to a pulsatile pump system and a heated water bath that constituted an in-vitro simulation unit. Delivery of the inferior vena cava implant was accomplished using a preloaded introducer and a dilator as a push rod to deploy the device at the target area. The anchors were subjected to manual compression tests to evaluate their stability against dislodgement. Computational Fluid Dynamics (CFD) analysis was completed to characterize blood flow in the anchor’s environment using pressure-based transient solver. Any potential recirculation zones or disturbances in the blood flow caused by the struts were identified. Results: We demonstrated successful anchorage and deployment of the 10-strut anchor in the Vena Cava bench model. The 10-strut anchor remained stable during several compression attempts as compared with the other two 5-strut anchor designs. The 10-strut design provided the maximum number of contact points with the vessel in a circular layout and was less susceptible to movement or dislodgement during compression tests. Furthermore, the CFD simulation provided haemodynamic analysis of the optimum 10-strut anchor design. Conclusions: This study successfully demonstrated the design and deployment of an inferior vena cava anchoring system in a bench test model. The 10-strut anchor is an optimal design as compared with the two other 5-strut designs; however, substantial in-vivo experiments are required to validate the safety and accuracy of such implants. The CFD simulation enabled better understanding of the haemodynamic parameters and any disturbances in the blood flow due to the presence of the anchor. The ability to place a sensor technology in the vena cava could provide a simple and minimally invasive approach for heart failure patients.

show abstract

Section: Introductionmentioning

confidence: 99%

Design and Haemodynamic Analysis of a Novel Anchoring System for Central Venous Pressure Measurement

Manavi

Ijaz

O’Grady

et al. 2022

Sensors

View full text Add to dashboard Cite

show abstract

High Inferior Vena Cava Diameter with High Left Ventricular End Systolic Diameter as a Risk Factor for Major Adverse Cardiovascular Events, Cardiovascular and Overall Mortality among Chronic Hemodialysis Patients

Yar

Kao

et al. 2022

JCM

View full text Add to dashboard Cite

Background: Little is known about the association of inferior vena cava diameter (IVCD) and left ventricular end-systolic diameter (LVESD) with mortality in patients undergoing hemodialysis (HD). Methods: The single medical center observational cohort study enrolled 241 adult chronic HD patients from 1 October 2018 to 31 December 2018. Echocardiography results of IVCD and LVESD prior to dialysis were retrieved and patients were divided into high IVCD and low IVCD groups. Patients who received HD via a tunneled cuffed catheter were excluded. Study outcomes included all-cause mortality, cardiovascular mortality, and major adverse cardiovascular events (MACE). Subgroup analyses of HD patients with high and low LVESD were also performed. Results: The incidence of all-cause mortality, cardiovascular mortality, and MACE were higher in chronic HD patients with high IVCD (p < 0.01). High IVCD patients had significantly greater all-cause mortality, cardiovascular mortality, and MACE (log-rank test; p < 0.05). High IVCD patients are also associated with an increased risk of all-cause mortality and MACE relative to low IVCD patients (aHRs, 2.88 and 3.42; 95% CIs, 1.06–7.86 and 1.73–6.77, respectively; all p < 0.05). In the subgroup analysis of patients with high or low LVESD, the high IVCD remained a significant risk factor for all-cause mortality and MACE, and the HR is especially high in the high LVESD group. Conclusions: Dilated IVCD is a risk factor for all-cause mortality and MACE in chronic HD patients. In addition, these patients with high LVESD also have a significantly higher HR of all-cause mortality and MACE.

show abstract

A Novel Non-Invasive Device for the Assessment of Central Venous Pressure in Hospital, Office and Home

Cited by 2 publications

References 78 publications

Design and Haemodynamic Analysis of a Novel Anchoring System for Central Venous Pressure Measurement

Design and Haemodynamic Analysis of a Novel Anchoring System for Central Venous Pressure Measurement

High Inferior Vena Cava Diameter with High Left Ventricular End Systolic Diameter as a Risk Factor for Major Adverse Cardiovascular Events, Cardiovascular and Overall Mortality among Chronic Hemodialysis Patients

Contact Info

Product

Resources

About